Kanagawa, Japan

Yoshihisa Ohta



Average Co-Inventor Count = 7.6

ph-index = 4

Forward Citations = 69(Granted Patents)


Location History:

  • Kanagawa, JP (2002 - 2011)
  • Yokohama, JP (2006 - 2011)

Company Filing History:


Years Active: 2002-2011

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Yoshihisa Ohta

Introduction

Yoshihisa Ohta is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of chemistry, particularly in the development of pharmaceutical compounds. With a total of 7 patents to his name, Ohta's work has had a considerable impact on medical research and drug development.

Latest Patents

Among his latest patents, Ohta has developed indazole derivatives, which provide a compound represented by a specific formula. This compound includes various substituents that can be hydrogen atoms, lower alkyl groups, aryl groups, and heterocyclic groups. Additionally, he has worked on thiadiazoline derivatives, which serve as antitumor agents. These derivatives are represented by a general formula and can include pharmacologically acceptable salts as active ingredients.

Career Highlights

Yoshihisa Ohta has had a distinguished career, working with prominent companies such as Kyowa Hakko Kogyo Co., Ltd. and Kyowa Hakko Kirin Co., Limited. His experience in these organizations has allowed him to contribute to various innovative projects and advancements in pharmaceutical research.

Collaborations

Throughout his career, Ohta has collaborated with esteemed colleagues, including Chikara Murakata and Kazuhiko Kato. These partnerships have fostered a collaborative environment that has led to the successful development of new compounds and research initiatives.

Conclusion

Yoshihisa Ohta's contributions to the field of chemistry and pharmaceuticals are noteworthy. His innovative patents and collaborations highlight his commitment to advancing medical science. Ohta's work continues to influence the development of new therapeutic agents, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…